dapivirine vaginal ring (25 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dapivirine vaginal ring (25 mg), covering 2022-10-25 to 2022-10-25. Get the full timeline:
Most recent: Clinical Trial Update: To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women [Phase 3]